Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
No new treatment results today — only links between heart, thyroid, and kidney health
Today brought no new clinical trial results for kidney disease treatments. Instead, two observational studies explored connections between heart health, thyroid function, and kidney outcomes — both show possible links but cannot confirm cause-and-effect. Most other items were policy calls, study plans, or background reviews.
Lack of association between Triglyceride glucose-body mass index and glomerular filtration rate in patients with coronary heart disease after percutaneous coronary intervention: a retrospective case-control study.
In 1,240 people with heart disease who had stents placed, researchers checked if a number called TyG-BMI (which combines triglycerides, blood sugar, and weight) predicted future kidney decline. They found no clear link — meaning this particular measure did not help predict how fast kidneys would worsen. Because it is an observational study, it shows a possible connection but cannot prove cause and effect.
Association of inadequately controlled hypothyroidism with major adverse cardiovascular events in type 2 diabetes patients receiving levothyroxine: a retrospective cohort study.
Researchers looked at 12,890 adults with type 2 diabetes and found that those whose thyroid levels stayed too high (meaning their levothyroxine dose was not right) had more heart problems like heart attacks and strokes. This study shows a link between poorly controlled thyroid disease and worse heart health, but it cannot prove that fixing the thyroid would prevent those events.